This Stock Has the Potencial to DoubleHere I present to you exclusively an undervalued share that few analysts have on their radar. The Cel-Sci share has recovered significantly from its lows reached in 2023 and formed a wave 1. There has been a correction, so we can expect big upward waves 3 and 5 soon. From an option sentiment perspec
Cel-Sci Corporation
0.2900USDR
−0.0139−4.57%
Last update at 20:55 GMT
0.2972USD
+0.0072+2.48%
No tradesPost-marketLast update at 20:42 GMT
Next report date
≈
May 19
Report period
Q2 2025
EPS estimate
—
Revenue estimate
—
−0.4704 USD
−26.92 M USD
0.00 USD
82.10 M
About Cel-Sci Corporation
Sector
Industry
CEO
Geert R. Kersten
Website
Headquarters
Vienna
Founded
1983
FIGI
BBG000H5G6L5
CEL-SCI Corp. is a clinical-stage biotechnology company, which engages in the research, development, and manufacture of investigational immunotherapy products for the treatment of cancer and infectious diseases. Its product pipeline includes Multikine and Ligand Epitope Presentation System (LEAPS). Multikine is an investigational immunotherapy for the potential treatment of head and neck cancers. LEAPS is categorized into LEAPS-H1N1-DC, a product candidate for the treatment of pandemic influenza for hospitalized patients and CEL-2000 and CEL-4000, which are vaccine candidates for the treatment of rheumatoid arthritis. The company was founded by Maximilian de Clara on March 22, 1983 and is headquartered in Vienna, VA.
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
−8.00 M
−6.00 M
−4.00 M
−2.00 M
0.00
Revenue
Net income
Net margin %
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
−8.00 M
−6.00 M
−4.00 M
−2.00 M
0.00
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
−8.00 M
−6.00 M
−4.00 M
−2.00 M
0.00
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
−5.00 M
0.00
5.00 M
10.00 M
15.00 M
Debt
Free cash flow
Cash & equivalents
No news here
Looks like there's nothing to report right now
CVM1Y
RSI is trending down.
MFI is trending down.
-Both have reached a top.
5Y
RSI is trending up.
MFI is trending up.
-Both have bottomed.
ALL
RSI is reaching a bottom.
MFI is trending down.
There is a gap around $0.80 and $1.
Prediction: I think we will continue falling near the $0.80 and $1 rang
AShort

CVM; Trend Analysis with ASCO reviewDisclaimer
I am very invested in CVM, for a multitude of reasons, first as a scientist, second as an investor, third as my ego. I believe their recent clinical trial results are phenomenal, and illustrate it's potential as the pre-treatment for cancer in immuno-competent patients with appropriate
ALong

CVM BullishPrice tested 4 fibonacci levels to close just under the .78 level. In addition the MACD just crossed on the daily.
Looks like $12.21 may act as resistance, in which case we may see a retracement to the $11.80-$11.22 level.
Target: $13.01 short term. $14.26-$16.71 possible if it starts to squeez.
ALong

CVM and Multikine; Rating and Confidence ReaffirmedDisclaimer
I am long $CVM to the tune of X0,000 shares (and growing). I genuinely believe, as a scientist, biochemist, and analyst, in Cel-Sci Corporation's Multikine. This article serves as the thesis that $CVM deserves that I have given to other stocks. As always buy shares, options are dangerous
ALong

Nice Long for CVM**SMALL ACCOUNT FRIENDLY PLAY**
Peep this insane chart!
**CVM**
Long above $12.50
Short below $11.22
$SPY $CVM
ALong

CVM; Breakout from bear pennant, prime for liftoffDisclaimer
General disclaimer here.
Short but sweet, we have sustained breakout from the bear pennant, we have a dwindling short pool (460k as of today borrowable from Fidelity, down from ~600k on Monday).
Less kick in the shorts, and they have until the 20th of this month to sustain the price c
ALong

CVM; Possible break of pennant into Gamma SqueezeDisclaimer
Not financial advice, blah blah blah.
Looking towards the end of current pennant into a gamma squeeze...
Options for 8/20 look like a massive gamma at 10 possible, with another big jump at 12.5 and 15. We could see a massive impulse up with intense gamma pressure from ~1.2 million shar
ALong

CVM; An Open Letter for a Large InvestorThis is an open letter to all large institutional investors with significant biotechnology/pharmaceutical experience.
The Company
Cel Sci Corp is a small, Immunology based biotech with a small pipeline outside of Multikine.
41 million shares outstanding with only State Street, BlackRock and Vangu
ALong

See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of CVM is 0.2900 USD — it has decreased by −4.57% in the past 24 hours. Watch Cel-Sci Corporation stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on AMEX exchange Cel-Sci Corporation stocks are traded under the ticker CVM.
CVM stock has risen by 16.93% compared to the previous week, the month change is a 28.99% rise, over the last year Cel-Sci Corporation has showed a −79.14% decrease.
We've gathered analysts' opinions on Cel-Sci Corporation future price: according to them, CVM price has a max estimate of 10.00 USD and a min estimate of 10.00 USD. Watch CVM chart and read a more detailed Cel-Sci Corporation stock forecast: see what analysts think of Cel-Sci Corporation and suggest that you do with its stocks.
CVM stock is 7.02% volatile and has beta coefficient of 1.54. Track Cel-Sci Corporation stock price on the chart and check out the list of the most volatile stocks — is Cel-Sci Corporation there?
Today Cel-Sci Corporation has the market capitalization of 25.57 M, it has increased by 11.32% over the last week.
Yes, you can track Cel-Sci Corporation financials in yearly and quarterly reports right on TradingView.
Cel-Sci Corporation is going to release the next earnings report on May 19, 2025. Keep track of upcoming events with our Earnings Calendar.
CVM net income for the last quarter is −7.07 M USD, while the quarter before that showed −6.11 M USD of net income which accounts for −15.77% change. Track more Cel-Sci Corporation financial stats to get the full picture.
No, CVM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CVM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Cel-Sci Corporation stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Cel-Sci Corporation technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Cel-Sci Corporation stock shows the sell signal. See more of Cel-Sci Corporation technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.